NO165744C - Fremgangsmaate for aa bevare virkningen av bakteriepreparater hvor bakteriene har sin opprinnelse fra tarmen til friske fjaerkre. - Google Patents

Fremgangsmaate for aa bevare virkningen av bakteriepreparater hvor bakteriene har sin opprinnelse fra tarmen til friske fjaerkre.

Info

Publication number
NO165744C
NO165744C NO850817A NO850817A NO165744C NO 165744 C NO165744 C NO 165744C NO 850817 A NO850817 A NO 850817A NO 850817 A NO850817 A NO 850817A NO 165744 C NO165744 C NO 165744C
Authority
NO
Norway
Prior art keywords
farmers
conserving
bacteria
fresh
original
Prior art date
Application number
NO850817A
Other languages
English (en)
Norwegian (no)
Other versions
NO165744B (no
NO850817L (no
Inventor
Antti Robert Mikkola
Heli-Riitta Marjaana Hakkinen
Lasse Olavi Nuotio
Esko Viljo Nurmi
Carita Elisabeth Schneitz
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of NO850817L publication Critical patent/NO850817L/no
Publication of NO165744B publication Critical patent/NO165744B/no
Publication of NO165744C publication Critical patent/NO165744C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
NO850817A 1984-03-01 1985-02-28 Fremgangsmaate for aa bevare virkningen av bakteriepreparater hvor bakteriene har sin opprinnelse fra tarmen til friske fjaerkre. NO165744C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI840816A FI840816A0 (fi) 1984-03-01 1984-03-01 Bakteriepreparat

Publications (3)

Publication Number Publication Date
NO850817L NO850817L (no) 1985-09-02
NO165744B NO165744B (no) 1990-12-27
NO165744C true NO165744C (no) 1991-04-10

Family

ID=8518638

Family Applications (1)

Application Number Title Priority Date Filing Date
NO850817A NO165744C (no) 1984-03-01 1985-02-28 Fremgangsmaate for aa bevare virkningen av bakteriepreparater hvor bakteriene har sin opprinnelse fra tarmen til friske fjaerkre.

Country Status (10)

Country Link
US (1) US4657762A (da)
EP (1) EP0154478A3 (da)
JP (1) JPH0759516B2 (da)
AU (1) AU581198B2 (da)
CA (1) CA1236400A (da)
DK (1) DK70385A (da)
ES (1) ES8605375A1 (da)
FI (1) FI840816A0 (da)
NO (1) NO165744C (da)
ZA (1) ZA85324B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910024A (en) * 1988-07-05 1990-03-20 Micro Chemical, Inc. Method and apparatus for administering live bacteria as feed additives to livestock and poultry
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
DE68928665T2 (de) * 1988-08-02 1998-11-12 Gastro Services Pty Ltd Behandlung von gastro-intestinalen krankheiten
US5206015A (en) * 1989-06-05 1993-04-27 The United States Of America As Represented By The Secretary Of Agriculture Introduction of bacteria in ovo
GB2233343B (en) * 1989-06-30 1993-07-07 Farmos Oy A bacterial preparation for use in poultry
US5139792A (en) * 1990-07-19 1992-08-18 Bio-Techniques Laboratories, Inc. Method and system for dispensing live bacteria into animal feed and drinking water
US5256425A (en) * 1991-08-19 1993-10-26 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
US5302388A (en) * 1991-11-13 1994-04-12 Wisconsin Alumni Research Foundation Control of campylobacter jejuni colonization
CA2156486C (en) * 1993-03-16 2002-11-12 Norman J. Stern Mucosal competitive exclusion flora
EP0801675B1 (en) * 1994-07-29 2003-04-16 The United States of America, as Represented by the Secretary, Department of Agriculture Saccharomyces treatment to diminish campylobacter and salmonella populations in poultry
US5722342A (en) * 1996-06-28 1998-03-03 Us Agriculure Ovo antibiotic and microbial treatment to dimenish salmonellae populations in avians
US5807546A (en) 1996-10-11 1998-09-15 The United States Of America As Represented By The Secretary Of Agriculture Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
AT407008B (de) * 1998-08-06 2000-11-27 Viernstein Helmut Dr Formulierungen mit probiotisch wirksamen mikroorganismen
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US20040241150A1 (en) * 2002-12-19 2004-12-02 Hargis Billy M. Defined competitive exclusion cultures for food borne pathogens
EP2351494A1 (en) 2005-03-18 2011-08-03 The United States of America as represented by the secretary of Agriculture Bacteriocins and novel bacterial strains
EA013330B1 (ru) 2005-03-18 2010-04-30 Де Юнайтед Стэйтс Оф Америка Эз Репрезентид Бай Де Секретэри Оф Агрикалчэ Бактериоцины и новые бактериальные штаммы
BR112013001107B1 (pt) 2010-07-16 2022-01-25 The Board Of Trustees Of The University Of Arkansas Métodos e composições incluindo bactéria formadora de esporos para aumento da saúde dos animais
CA2807242C (en) 2010-08-04 2017-05-02 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
US9107938B2 (en) 2010-09-30 2015-08-18 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
BR112013022927A2 (pt) 2011-03-09 2016-12-06 Univ Minnesota composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
WO2014022572A1 (en) 2012-08-01 2014-02-06 Pacific Vet Group-Usa, Inc. Probiotic for amelioration of coccidiosis vaccine reaction
US10420783B2 (en) 2013-06-20 2019-09-24 Mars, Incorporated Performance food product
CN114159476A (zh) 2015-05-14 2022-03-11 克雷斯顿沃控股公司 用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
CN114366759A (zh) 2015-05-22 2022-04-19 亚利桑那大学董事会 用于治疗自闭症谱系障碍及相关症状的方法
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
CN110996917A (zh) 2017-05-26 2020-04-10 克雷斯顿沃控股公司 包含基于粪便微生物的治疗剂的冻干组合物及其制造和使用方法
KR20200038506A (ko) 2017-08-07 2020-04-13 핀치 테라퓨틱스, 인코포레이티드 건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CN113164527A (zh) 2018-09-27 2021-07-23 芬奇治疗控股有限责任公司 用于治疗癫痫和相关障碍的组合物和方法
WO2021016081A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953609A (en) * 1974-02-06 1976-04-27 Microlife Technics, Inc. Method for the growth restriction of undesirable digestive system bacteria in animals and the establishment of lactobacillus lactis NRRL B-5628
US4030978A (en) * 1976-07-29 1977-06-21 Becton, Dickinson And Company Novel assembly, compositions and methods
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
FI59925C (fi) * 1980-01-11 1981-11-10 Esko Viljo Nurmi Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
US4251509A (en) * 1980-01-31 1981-02-17 Wisconsin Alumni Research Foundation Dry particulate vaccine for oral administration

Also Published As

Publication number Publication date
NO165744B (no) 1990-12-27
AU581198B2 (en) 1989-02-16
DK70385D0 (da) 1985-02-15
EP0154478A3 (en) 1987-06-10
DK70385A (da) 1985-09-02
US4657762A (en) 1987-04-14
EP0154478A2 (en) 1985-09-11
NO850817L (no) 1985-09-02
JPH0759516B2 (ja) 1995-06-28
ES540375A0 (es) 1986-03-16
ES8605375A1 (es) 1986-03-16
ZA85324B (en) 1985-08-28
FI840816A0 (fi) 1984-03-01
AU3758085A (en) 1985-09-05
CA1236400A (en) 1988-05-10
JPS60202823A (ja) 1985-10-14

Similar Documents

Publication Publication Date Title
NO822926L (no) Fremgangsmaate for fremstilling av polypeptider i cellekultur fra virveldyr.
NO850817L (no) Fremgangsmaate for aa bevare effektiviteten til bakteriepreparater
NO155290C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme sulfonylurinstoffderivater.
NO153202C (no) Fremgangsmaate for fremstilling av et enzymatisk totalhydrolysat fra myseproteiner.
NO166865C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive o-glykosidforbindelser.
NO166367C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO157861C (no) Analogifremgangsmaate til fremstilling av aminopyridaziner.
IT8220139A0 (it) Procedimento di micro-incapsulamento, particolarmente di colture di cellule.
NO157738C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazinoner og benzoksazolinoner.
NO152649C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive fenylalkylaminer.
NO161066C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO813079L (no) Fremgangsmaate til plantedyrkning uten jord.
NO163775C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO158948C (no) Fremgangsmaate for fremstilling av enzymet kolesterase.
NO160484C (no) Fremgangsmaate for fremstilling av fermentert myse.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO162079C (no) Fremgangsmaate for fremstilling av helcellepreparater eller celleveggpreparater av propionibakterier for behandling av tumorer.
IT7922818A0 (it) Procedimento per mantenere attiva la cultura di fermenti.
NO793590L (no) Fremgangsmaate til fremstilling av klordioksyd, alkalilut og eventuelt klor.
NO159080C (no) Fremgangsmaate til fremstilling av 2,4-diklor-5-fluor-benzosyre.
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
ES516007A0 (es) Procedimiento para intensificar conversiones microbiologicas de esteroides.
IT7819138A0 (it) Procedimento per la coltura di microrganismi.
RO75739A (ro) Procedeu pentru prepararea unor carbamoil triazolil-o,n-acetali
NO162758C (no) Fremgangsmaate til fjernelse av kadmium fra raafosfat.